Patents by Inventor Daniel Wei
Daniel Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12254163Abstract: An object folding tool is leveraged in a digital medium environment. A two-dimensional (2D) representation of an unfolded object is obtained, and visual cues indicating folds for transforming the unfolded object into a folded object are detected. Based on the detected visual cues, a shape of the folded object is determined, and a three-dimensional (3D) representation of the folded object having the determined shape is generated. In one or more implementations, the 2D representation of the unfolded object and the 3D representation of the folded object are displayed concurrently on a display device.Type: GrantFiled: March 7, 2019Date of Patent: March 18, 2025Assignee: Adobe Inc.Inventors: Michal Lukac, Amanda Paige Ghassaei, Wilmot Wei-Mau Li, Vidya Narayanan, Eric Joel Stollnitz, Daniel Max Kaufman
-
Patent number: 12247394Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: GrantFiled: October 27, 2023Date of Patent: March 11, 2025Assignee: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Publication number: 20250064958Abstract: Provided herein are APP RNAi agents and compositions comprising an APP RNAi agent. Also provided herein are methods of using the APP RNAi agents or compositions comprising an APP RNAi agent in reducing APP expression and/or treating APP associated neurological diseases.Type: ApplicationFiled: August 16, 2024Publication date: February 27, 2025Inventors: Riazul ALAM, Jee-Wei Emily CHEN, Carrie Hughes CROY, David Albert DRIVER, Sarah Katharina FRITSCHI, Daniel Scott GIRARD, Isabel C. GONZALEZ VALCARCEL, Ruben Martin MARTINEZ, Rebecca Ruth MILES, Hatice Gulcin OZER, Douglas Raymond PERKINS, Jibo WANG
-
Publication number: 20250045316Abstract: An example method includes providing, to a sequence model (i) a plurality of few-shot prompts, wherein each prompt comprises a demonstration passage, a demonstration task, and a demonstration query, wherein the demonstration task describes a type of retrieval, and wherein the demonstration query is relevant to the demonstration task, and (ii) a plurality of passages sampled from a corpus of passages. The method also includes receiving, from the sequence model and for the plurality of passages and based on the plurality of few-shot prompts, a respective plurality of predicted task-query pairs, the sequence model having been prompted to predict a task based on an input passage, and predict an output query relevant to the predicted task. The method further includes generating a synthetic training dataset comprising the plurality of passages and the respective plurality of predicted task-query pairs. The method also includes providing the synthetic training dataset.Type: ApplicationFiled: July 30, 2024Publication date: February 6, 2025Inventors: Jinhyuk Lee, Zhuyun Dai, Xiaoqi Ren, Iftekhar Naim, Yi Luan, Blair Yuxin Chen, Siddhartha Reddy Jonnalagadda, Ming-Wei Chang, Daniel Matthew Cer, Gustavo Adolfo Hernandez Abrego, Jeremy Robert Cole, Colin Hearne Evans, Yuzhe Zhao, Pranay Bhatia, Rajvi Kapadia, Riham Hassan Abdel-Moneim Mansour, Raphael Dominik Hoffman, Simon Kunio Tokumine, Scott Bradley Huffman, Stephen Zachary Karukas, Michael Yiupun Kwong, Shu Zheng, Yan Qiao, Lukas Rutishauser, Anand Rajan Iyer
-
Publication number: 20250044847Abstract: In some examples, an electronic device comprises a processor and a power circuit coupled to the processor. The power circuit is to provide power to the processor and to measure a current drawn from the power circuit by the processor. The electronic device also comprises a voltage regulator controller coupled to the processor and the power circuit. The voltage regulator controller is to receive a current usage prediction from the processor, receive the measurement from the power circuit, compare the current usage prediction and the measurement, and, based on the comparison, drive the power circuit in accordance with the measurement instead of the current usage prediction.Type: ApplicationFiled: October 22, 2024Publication date: February 6, 2025Applicant: Hewlett-Packard Development Company, L.P.Inventors: Fangyong Dai, Qijun Chen, Ann Alejandro Villegas, Ling Wei Chung, Daniel Joseph Luc
-
Patent number: 12215157Abstract: Multi-specific binding proteins that bind to and kill human cancer cells expressing CD33 (Siglec-3) are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of CD33 expressing cancer. The invention relates to multi-specific binding proteins that bind to human cancer cells expressing CD33 and exhibit high potency and maximum lysis of target cells compared to anti-CD33 monoclonal antibodies. The multi-specific binding proteins comprise a CD33-binding domain, an NKG2D-binding domain and a CD16-binding domain.Type: GrantFiled: February 20, 2019Date of Patent: February 4, 2025Assignee: Dragonfly Therapeutics, Inc.Inventors: Gregory P. Chang, Ann F. Cheung, Asya Grinberg, Dhruv Kam Sethi, William Haney, Bianka Prinz, Bradley M. Lunde, Ronnie Wei, Daniel Fallon, Steven O'Neil
-
Publication number: 20250033032Abstract: Disclosed herein is a material for use in sorbent-based dialysis, the material comprising: acidic and/or neutral cation exchange particles; alkaline anion exchange particles; and one or more of an alkali metal carbonate, a water insoluble alkaline earth metal carbonate, and a water insoluble polymeric ammonium carbonate. Also disclosed herein are uses of said material and its preparation.Type: ApplicationFiled: November 29, 2022Publication date: January 30, 2025Inventors: Suresha BELURE VENKATARAYA, Mandar Manohar GORI, Sanjay Kumar SINGH, Joel Preetham FERNANDES, Daniel Wei Teik TAN, Marcin Bartlomiej PAWLAK, Sridhar CHIRUMARRY, Vinod Kumar GADI, Jason Tze Chern LIM, Yue (Victoria) WANG, Peter HAYWOOD
-
Patent number: 12206729Abstract: A technique may include receiving, by a management service a plurality of instance configurations from a client device. The technique may then include receiving, by the management service, information identifying a launch request for a compute instance. The technique may include determining, by the management service, one or more candidate shapes for the compute instance based at least in part on the plurality of instance configurations. The technique may include selecting, by the management service and from the one or more candidate shapes, a launch shape for the compute instance and launching the compute instance using the launch shape. The technique may then include providing, the client device access to the compute instance, launched based on the launch shape.Type: GrantFiled: April 7, 2023Date of Patent: January 21, 2025Assignee: Oracle International CorporationInventors: Jonathan Luke Herman, Art Plata, Joshua Potter, John Matthew Mullins, Nathan Cook, Nathan Turner, Tianyi Wei, Amit Vasudevan, Haifeng Ren, Harsh Verma, Jiafeng Yang, John David Martinez, Daniel Stuart Goldfein, Mahima Tomer
-
Publication number: 20240368144Abstract: The present invention relates to N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds of Formulae (IA and 1B) or a pharmaceutically acceptable salt or hydrate thereof, that inhibit CC chemokine receptor 6 (CCR6), pharmaceutical compositions containing these compounds, and the use of these compounds for treating or preventing diseases, conditions, or disorders ameliorated by inhibition of CCR6.Type: ApplicationFiled: May 3, 2023Publication date: November 7, 2024Applicant: Pfizer Inc.Inventors: Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant, Ralph Pelton Robinson, JR., Daniel Copley Schmitt, Mark Edward Schnute, Atli Thorarensen, John Isidro Trujillo, Rayomand Jal Unwalla, Huixian Wu
-
Publication number: 20240351688Abstract: The present invention relates to an aircraft galley, and a method and apparatus for configuring the same. The aircraft galley includes: a frame attached to walls of a cabin of an aircraft in a horizontal direction and has an open accommodating space; one or more first to third cabinet assemblies all detachably connected to the frame, wherein the sizes of the first to third cabinet assemblies and the accommodating space are in a predetermined proportion to each other, such that the space can be filled with different combinations formed by at least two of the first to third cabinet assemblies, and the different combinations differ in at least one of: types of cabinet assemblies, the number of each type of the cabinet assemblies, and the arranged position of each cabinet assembly. Therefore, the technical effects of improving the utilization efficiency of the aircraft galley and reducing airline costs are achieved.Type: ApplicationFiled: February 21, 2024Publication date: October 24, 2024Applicant: The Boeing CompanyInventors: Paola Trapani, Jiao Mo, Ke Ma, Peizhong Gao, Qian Guo, Yiqin Zhang, Youjia Shen, Jiawen Huang, Daniel Wei, Cynthia A. Vandewall
-
Publication number: 20240336572Abstract: The invention relates to substituted indazole propionic acid derivatives, pharmaceutically acceptable salts, tautomers, or pharmaceutically acceptable salts of the tautomers thereof that can activate adenosine 5?-monophosphate-activated protein kinase (AMPK). The invention further relates to pharmaceutical compositions comprising AMPK-activating substituted indazole propionic acid derivatives, pharmaceutically acceptable salts, tautomers, or pharmaceutically acceptable salts of the tautomers thereof and at least one pharmaceutically acceptable excipient, and methods of treating a condition comprising administering AMPK-activating substituted indazole propionic acid derivatives, pharmaceutically acceptable salts, tautomers, or pharmaceutically acceptable salts of the tautomers thereof.Type: ApplicationFiled: April 4, 2024Publication date: October 10, 2024Applicant: Pfizer Inc.Inventors: Samit Kumar Bhattacharya, Edward Lee Conn, David Christopher Ebner, Brian Stephen Gerstenberger, Chan Woo Huh, Daniel Wei-Shung Kung, Alan Martin Mathiowetz, Jessica Gloria Katherine O'Brien, Meihua Mike Tu, Kimberly O'Keefe Cameron, Dilinie Prasadhini Fernando, Kevin James Filipski, Esther Cheng Yin Lee, Sarah Jane Mear, Aaron Christopher Smith
-
Publication number: 20240271277Abstract: In some aspects of the present disclosure, a method includes performing an atomic layer deposition (ALD) process to form an antimony-containing coating of a surface of a substrate. The ALD process includes providing a first reactant to the surface of the substrate. The first reactant adsorbs onto the surface to form an adsorption layer thereon. The ALD process further includes providing a second reactant to the surface of the substrate. The second reactant includes a reducing agent. The second reactant reacts with the adsorption layer to form a layer of the antimony-containing coating. The ALD process further includes repeating the providing of the first reactant and the providing of the second reactant one or more times to form the antimony-containing coating.Type: ApplicationFiled: February 9, 2024Publication date: August 15, 2024Inventors: Thomas Joseph Knisley, Zachary Joseph Devereaux, Charles Hartger Winter, Daniel Wei Ming Beh
-
Patent number: 12030149Abstract: A method for sensing a cutting-edge load in a motor-driven machine-tool unit having a stator unit and a rotor unit that is rotatable at least about an axis of rotation. The rotor unit includes a tool receiving unit that is adjustable along the axis of rotation and to which a clamping force can be applied, for fixing and clamping a releasably fixable tool shank of a tool. A tool head of the tool includes at least one individual cutting edge. A tool sensor is provided for sensing the load on the tool, the tool sensor being realized as an individual-cutting-edge sensor for sensing a cutting-edge load on the individual cutting edge.Type: GrantFiled: June 2, 2021Date of Patent: July 9, 2024Assignee: Franz Kessler GmbHInventors: Joachim Van Sprang, Harald Weing, Daniel Weiß
-
Publication number: 20240124450Abstract: A compound of formula I having the structure: or a pharmaceutically acceptable salt thereof, wherein A1 and A2 are independently O or S; X is selected from CH2, CD2, NR3, O, and S, where R3 is selected from hydrogen, C1-C4 linear or branched chain alkyl, halo(C1-C4)linear or branched chain alkyl, and hydroxyl(C1-C4)linear or branched chain alkyl; Y and Z are selected from C and N, where when Y is C, then Z is N, and when Y is N, then Z is C; R1 and R2 are independently selected from hydrogen, deuterium, C1-C4 linear or branched chain alkyl, etc.; or a C1-C2 alkyl substituted with a C3-C5 cycloalkyl ring; or taken together to form a C3-C6 cycloalkyl ring; or where X is CH2 or CD2, then R1 and R2 are independently selected from hydrogen, deuterium, halogen, hydroxyl, C1-C4 linear or branched chain alkyl, etc.; R4 is selected from hydrogen, deuterium, cyano, halogen, (C1-C3) alkoxy, etc.; R5 is selected from hydrogen, deuterium, halogen, C1-C3 alkoxy, amino, (C1-C4 linear or branched chain alkyl)amino, etc.Type: ApplicationFiled: September 13, 2023Publication date: April 18, 2024Applicant: Pfizer Inc.Inventors: Andrea Nicole Bootsma, David Christopher Ebner, Daniel Wei-Shung Kung, Matthew Alexander Perry, Daniel Copley Schmitt, Joseph Walter Strohbach, Atli Thorarensen
-
Publication number: 20240060296Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: ApplicationFiled: October 27, 2023Publication date: February 22, 2024Applicant: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Patent number: 11885123Abstract: An inflatable partition includes a flexible membrane, an inflatable frame, and a support member coupled to the inflatable frame. The inflatable frame extends along a periphery of the flexible membrane and has an inner edge adjacent to the flexible membrane and an outer edge. The inflatable frame further includes a sealing mechanism extending along at least a portion of the outer edge and the inflatable frame is inflatable between a first state and a second state. The inflatable partition includes a first structural member and a second structural member. Each of the first and second structural members is coupled to the inflatable frame and extends vertically from the upper portion to the bottom portion of the inflatable frame and the first and second structural members define an opening in the inflatable partition.Type: GrantFiled: December 15, 2021Date of Patent: January 30, 2024Assignee: The Boeing CompanyInventors: Liu Weiqiang, Zhongzhe Dong, Long Long, Daniel Wei
-
Patent number: 11771523Abstract: The present invention relates to a method for the design and manufacture of a dental component with a surface, wherein a 3D model of the dental component is designed by means of a CAD unit and the dental component is manufactured by a CAM unit on the basis of the 3D model.Type: GrantFiled: December 10, 2019Date of Patent: October 3, 2023Assignee: DENTSPLY SIRONA INC.Inventors: Hans-Christian Schneider, Oliver Nowarra, Daniel Weiß, Peter Fornoff
-
Publication number: 20230256149Abstract: The current invention relates to a peritoneal dialysis filter device, which comprises a housing comprising a first port and a second port, and a hollow fibre membrane formed from hollow hydrophilic fibres within the housing. When in use, a dialysate from a subject enters the filter device through the first port and exits via the second port in an outflow direction, and a regenerated dialysate from a sorbent system enters the filter device through the second port and exits via the first port in an inflow direction. Also disclosed herein is a peritoneal dialysis system comprising said filter device, a method for controlling dialysate flow in a peritoneal dialysis system, and a haemodialysis device.Type: ApplicationFiled: June 28, 2021Publication date: August 17, 2023Inventors: Jason Tze Chern LIM, Peter HAYWOOD, Suresha BELUR VENKATARAYA, Joel Preetham FERNANDES, Daniel Wei Teik TAN, Yue WANG, Abel Samson DSOUZA, Wenhui Dennis ONG, Sanjay Kumar SINGH
-
Publication number: 20230242259Abstract: Provided is an air diffuser and a construction method thereof. The air diffuser is especially applied to the field of civil aircrafts. The air diffuser comprises: an open upper end part; an open lower end part; and an air flow passage defined between the open upper end part and the open lower end part, the air flow passage comprising a first side wall and a second side wall which are connected between the open upper end part and the open lower end part and are symmetrically located with respect to a vertical center plane of the air diffuser; wherein the section outline of each of the first side wall and the second side wall has a curved shape bending inwards, such that in a direction from the open upper end part to the open lower end part, the air flow passage has, in sequence, a contraction portion bending toward the vertical center plane and an expansion portion away from the vertical center plane.Type: ApplicationFiled: June 9, 2021Publication date: August 3, 2023Applicant: The Boeing CompanyInventors: Chun Chen, Yue Pan, Chao-Hsin Lin, Daniel Wei
-
Patent number: 11708360Abstract: The present invention relates to N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamide compounds of Formulae (IA and 1B) or a pharmaceutically acceptable salt or hydrate thereof, that inhibit CC chemokine receptor 6 (CCR6), pharmaceutical compositions containing these compounds, and the use of these compounds for treating or preventing diseases, conditions, or disorders ameliorated by inhibition of CCR6.Type: GrantFiled: March 5, 2021Date of Patent: July 25, 2023Assignee: Pfizer Inc.Inventors: Brian Stephen Gerstenberger, Andrew Christopher Flick, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant, Ralph Pelton Robinson, Jr., Daniel Copley Schmitt, Mark Edward Schnute, Atli Thorarensen, John Isidro Trujillo, Rayomand Jal Unwalla, Huixian Wu